- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT02834013 | Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
707 | All | 18 Years and older (Adult, Senior) | NCT02834013 | NCI-2016-01041 S1609 U10CA180888 |
January 13, 2017 | August 31, 2020 | July 15, 2016 | April 24, 2018 |
|